Aesthetic injectables are generally well tolerated when delivered by appropriately trained medical professionals. Yet the signs of filler vascular occlusion must be recognised without hesitation. This rare but time-critical complication can compromise blood supply to the skin and, in exceptional circumstances, threaten vision. The difference between an excellent recovery and permanent injury may be determined by early recognition, decisive escalation and a rehearsed clinical response.
Vascular occlusion occurs when filler obstructs, compresses or enters a blood vessel, reducing tissue perfusion. It is not a complication to observe passively or manage through reassurance alone. Any suspected event requires urgent assessment by a clinician competent in complications management, with immediate action guided by the product used, the anatomy involved and the patient’s evolving clinical signs.
Why filler vascular occlusion demands urgency
The skin, subcutaneous tissues and eyes depend on a constant arterial blood supply. When that supply is disrupted, tissues become ischaemic. Initially, the changes may be subtle and reversible. As ischaemia persists, however, cellular injury progresses and can lead to blistering, ulceration, scarring or tissue loss.
For clinicians, the central principle is straightforward: treat the clinical picture, not a single isolated symptom. A patient may not report severe pain. Blanching may be fleeting or may be disguised by swelling, make-up, skin tone or post-injection erythema. Conversely, discomfort and pallor can occasionally arise from local anaesthetic containing adrenaline, anxiety or pressure from oedema. The appropriate response to uncertainty is not delay, but careful reassessment and a low threshold for escalation.
Visual symptoms require an emergency response. Sudden visual disturbance after filler treatment, including blurred vision, reduced visual field, double vision, eye pain or loss of vision, should be treated as an ophthalmic emergency. Immediate emergency transfer and specialist ophthalmology involvement are essential. No clinic should undertake injectable practice without clear emergency pathways for such events.
Early signs of filler vascular occlusion
The presentation varies according to the vessel affected, the injection plane, the volume and rheology of the product, and the extent to which collateral circulation can compensate. Nonetheless, a recognisable pattern is often present.
Pain that is disproportionate or escalating
Sudden, severe or increasing pain during or after injection is a significant warning sign, particularly when it occurs beyond the immediate injection point or tracks along a known vascular territory. Patients may describe burning, intense pressure, throbbing or pain that feels markedly different from the expected discomfort of treatment.
Pain alone is not diagnostic. Some vascular events are relatively painless, especially where local anaesthetic is used or when a small distal territory is involved. But disproportionate pain should always prompt inspection of capillary refill, skin colour, temperature and distribution of symptoms.
Blanching and delayed capillary refill
Pallor or blanching of the skin may appear immediately, or shortly after treatment. It can be sharply localised, patchy or extend in a branching pattern away from the injection site. On gentle pressure, capillary refill may be delayed compared with adjacent untreated skin.
This finding deserves particular attention in high-risk facial regions, including the glabella, nose, forehead, temple, nasolabial fold and lips. Anatomy is variable, and no area should be regarded as risk-free. The apparent location of an injection does not always correspond to the full territory supplied by the vessel involved.
Mottling, livedo and colour change
As perfusion deteriorates, blanching may develop into an irregular, dusky or violaceous mottling known as livedo reticularis. The skin can take on a marbled appearance, sometimes following the course of a vessel or spreading across a broader vascular territory.
A pale area that later becomes blue, grey, purple or dusky should never be dismissed as ordinary bruising. Bruising usually evolves more gradually and does not typically produce a reticular pattern, delayed capillary refill or escalating pain. Careful serial photography, taken with appropriate consent and without delaying treatment, can help document progression and support communication with specialist colleagues.
Coolness, altered sensation and later skin breakdown
Affected skin may feel cooler than the surrounding area. Patients can also experience numbness, tingling or altered sensation. With continuing ischaemia, blistering, epidermal sloughing and ulceration may occur. These are late signs, not milestones to await before intervention.
The aim of early complications management is to restore perfusion before tissue damage becomes established. Once necrosis is visible, the clinical task broadens to wound care, infection prevention, pain control, scar management and compassionate long-term follow-up.
A pattern matters more than one symptom
A thoughtful assessment considers timing, anatomy and progression. Blanching confined to the immediate injection site that resolves promptly may reflect vasoconstriction from local anaesthetic. Mild tenderness and redness can be normal post-procedure effects. However, persistent pallor, worsening pain, a livedoid pattern, delayed capillary refill or changes extending beyond the treatment area demand a different level of concern.
It is equally important to appreciate that vascular compromise can present after the patient has left the clinic. Swelling, vessel compression and evolving obstruction may make signs more apparent over the following hours. Patients should receive clear written and verbal safety-netting before they leave, including a direct route for urgent contact outside routine hours. They should understand that unusual pain, whitening, mottling, darkening skin or any visual symptom is not something to wait on until the next working day.
Immediate action in the clinic
When vascular occlusion is suspected, the injector should stop treatment immediately. The patient should be assessed in good lighting, with examination of colour, capillary refill, temperature, pain and the full anatomical distribution of the change. Clinical photographs and precise documentation are valuable, but must not displace urgent care.
For hyaluronic acid filler, clinicians trained in the management of vascular compromise should initiate their established hyaluronidase-based emergency protocol without delay. The protocol should be current, accessible and supported by appropriate stock, consent processes, anaphylaxis preparedness and staff training. Reassessment must be frequent because the response may require repeated treatment and because the visible territory can evolve.
Where a non-hyaluronic filler has been used, management is more complex and specialist input is especially important. There is no universal reversal agent for every material. This is one reason why product selection, traceability and a detailed treatment record are fundamental components of safe practice.
Adjunctive measures are sometimes used within specialist protocols, but they are not substitutes for restoring perfusion or arranging emergency care where indicated. Clinicians should avoid relying on unproven measures, avoid sending a symptomatic patient home for observation, and avoid allowing administrative uncertainty to delay escalation.
Vision changes are a separate emergency
Any new visual disturbance during or after facial filler requires immediate emergency action. Symptoms may include sudden loss or reduction of vision, blurred vision, a dark curtain or field defect, double vision, severe ocular pain, ptosis, nausea or headache. The absence of skin changes does not make these symptoms less serious.
The priority is urgent transfer through emergency medical services and direct communication with ophthalmology where possible. Time spent attempting to resolve a visual event in a non-specialist setting can be harmful. Every aesthetic clinic should rehearse this pathway, know its local emergency contacts and ensure all staff understand their respective roles.
Prevention begins before the needle touches skin
The safest complication is the one prevented through sound clinical judgement. Prevention begins with an anatomical consultation rather than a product-led appointment. This includes a full medical history, assessment of previous filler, discussion of realistic outcomes and consideration of whether treatment is appropriate at all.
For injectors, prevention depends on advanced anatomical knowledge, respect for high-risk planes, conservative volumes, controlled injection technique and continuous observation of the patient. Needle and cannula choice can alter risk but neither eliminates it. Aspiration may provide information in some contexts, yet a negative aspiration result cannot guarantee safety and must never create false reassurance.
Clinics should maintain complication kits, documented protocols and regular team simulation. A protocol that has not been practised is not a dependable emergency system. Professor Patrick Treacy’s longstanding emphasis on complications education reflects a wider responsibility within aesthetic medicine: technical skill must be matched by the ability to recognise, manage and communicate risk with clinical discipline.
What patients should do if they are worried
Patients should contact their treating clinic urgently if they notice severe or worsening pain, whitening, mottled or dusky skin, unusual coolness, blisters, numbness or a rapidly changing area after filler. Any visual symptom warrants an emergency call and immediate assessment through emergency services.
Do not massage aggressively, apply unadvised products or wait for a photograph-based reply if symptoms are progressing. Bring details of the treatment, including the date, product and area injected, if emergency clinicians request them. A responsible aesthetic provider will regard a concern of this nature as urgent, assess it promptly and coordinate onward care when necessary.
The enduring standard in aesthetic medicine is not simply to achieve a refined result. It is to pair every procedure with the anatomical knowledge, emergency preparedness and professional judgement that protect the patient when the unexpected occurs.